Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Feb 20, 2018. Reported reason: Delay in shipping of the drug

Shortage details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
63323-462-31
Dosage Form
Injection
Presentation
Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-31)
Initial Posting
Feb 20, 2018

Reason

Delay in shipping of the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.